January 25, 2010 CONFIDENTIAL
Exhibit (d)(6)
January 25, 2010
CONFIDENTIAL
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Chairman of the Special Committee of the Board of Directors
Global Med Technologies, Inc.
c/o ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ and ▇▇▇▇, P.C.
One Civic Center Plaza
▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Chairman of the Special Committee of the Board of Directors
Global Med Technologies, Inc.
c/o ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ and ▇▇▇▇, P.C.
One Civic Center Plaza
▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Dear ▇▇▇▇▇,
Reference is made to the letter agreement, dated December 2, 2009 (the “Exclusivity
Letter”), by and between Global Med Technologies, Inc. (“Global Med”) and Haemonetics
Corporation (“Haemonetics”). The purpose of this letter is to confirm the agreement between Global
Med and Haemonetics that the Exclusivity Period (as defined in the Exclusivity Letter) shall be
recommenced on the date hereof and extended until 11:59 p.m. Mountain Time on January 31, 2010,
subject to §6 of the Exclusivity Letter. Subject only to the foregoing, the terms of the
Exclusivity Letter shall be incorporated herein by reference and shall be in full force and effect
as of the date hereof.
Please indicate the agreement of Global Med to the foregoing by executing one copy of this
letter in the space provided below and returning a copy to the undersigned at your earliest
convenience.
Sincerely,
Haemonetics Corporation |
||||
By: | /s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ | |||
▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ | ||||
Chief Financial Officer, VP — Business Development |
||||
Accepted and agreed:
Global Med Technologies, Inc. |
||||
By: | /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |||
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||||
Chairman, Special Committee of the Board of Directors |
||||